Zohreh Amoozgar

Alıntı yapanlar

	Hepsi	2019 yılından bugüne
Alıntılar	6641	5268
h-endeksi	32	28
i10-endeksi	42	39

1300

650

325

975

201220132014201520162017201820192020202120222023202433 59 98 117 189 341 430 575 799 1031 1171 1262 428

Genel erişim

Tümünü görüntüle

23 makale

6 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Dan G. Duda, DMD, PhDProfessor of Radiation Oncology, Massachusetts General Hospital and Harvard Medical Schoolpartners.org üzerinde doğrulanmış e-posta adresine sahip
Yoon YeoIndustrial and Molecular Pharmaceutics, Biomedical Engineering, Purdue Universitypurdue.edu üzerinde doğrulanmış e-posta adresine sahip
Jonas KloepperOnkoZentrum Zürich AGozh.ch üzerinde doğrulanmış e-posta adresine sahip
Ana BatistaElseviercell.com üzerinde doğrulanmış e-posta adresine sahip
Joonyoung ParkPurdue Universitypurdue.edu üzerinde doğrulanmış e-posta adresine sahip
Walid KamounTakedatakeda.com üzerinde doğrulanmış e-posta adresine sahip
Jermaine GoveiaPhD candidate, KU Leuvenvib-kuleuven.be üzerinde doğrulanmış e-posta adresine sahip
Trupti VardamMayo Clinicmayo.edu üzerinde doğrulanmış e-posta adresine sahip
Victoria KüttnerPostdoc, Cold Spring Harbor Laboratorycshl.edu üzerinde doğrulanmış e-posta adresine sahip
Ana S. AlmeidaPrincipal Investigator at Instituto de Medicina Molecular João Lobo Antunesmedicina.ulisboa.pt üzerinde doğrulanmış e-posta adresine sahip
Kai Kessenbrock, Ph.D.Assistant Professor - University of California, Irvineucsf.edu üzerinde doğrulanmış e-posta adresine sahip
Deyin XingJohns Hopkins Universityjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Giorgio SeanoTumor Microenvironment Lab, Institut Curie (Paris)curie.fr üzerinde doğrulanmış e-posta adresine sahip
michael carrollProfessor of Pediatrics, Harvard Medical Schoolchildrens.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Fatemeh AhmadiAssociate Professor of Pharmaceutics, Shiraz University of Medical Sciencessums.ac.ir üzerinde doğrulanmış e-posta adresine sahip
Soliman Mohammadi SamaniProfessor of Pharmaceutics, School of pharmacy, Shiraz University of Medical Sciences, Shiraz, Iransums.ac.ir üzerinde doğrulanmış e-posta adresine sahip
Lotte SpelUniversity of Lausanneunil.ch üzerinde doğrulanmış e-posta adresine sahip
Chad TuchekUniversity of Kansas Medical Centerkumc.edu üzerinde doğrulanmış e-posta adresine sahip
Habib FirouzabadiChemistry Department, College of Sciences, Shiraz University, Shiraz 71454, Iranmail.susc.ac.ir üzerinde doğrulanmış e-posta adresine sahip
Mohammad H. SalehDana-Farber Cancer Institute; University of Torontomail.utoronto.ca üzerinde doğrulanmış e-posta adresine sahip

Takip et

Zohreh Amoozgar

MGH, Harvard Medical School

mgh.harvard.edu üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

drug delivery tumor immunology tumor biology


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges D Fukumura, J Kloepper, Z Amoozgar, DG Duda, RK Jain Nature reviews Clinical oncology 15 (5), 325-340, 2018	1412	2018
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps J Park, RW Wysocki, Z Amoozgar, L Maiorino, MR Fein, J Jorns, AF Schott, ... Science translational medicine 8 (361), 361ra138-361ra138, 2016	798	2016
Chitosan based hydrogels: characteristics and pharmaceutical applications F Ahmadi, Z Oveisi, SM Samani, Z Amoozgar Research in pharmaceutical sciences 10 (1), 1-16, 2015	600	2015
Recent advances in stealth coating of nanoparticle drug delivery systems Z Amoozgar, Y Yeo Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 4 (2 …, 2012	562	2012
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival J Kloepper, L Riedemann, Z Amoozgar, G Seano, K Susek, V Yu, ... Proceedings of the National Academy of Sciences 113 (16), 4476-4481, 2016	318	2016
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival J Kloepper, L Riedemann, Z Amoozgar, G Seano, K Susek, V Yu, ... Proceedings of the National Academy of Sciences 113 (16), 4476-4481, 2016	318	2016
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages TE Peterson, ND Kirkpatrick, Y Huang, CT Farrar, KA Marijt, J Kloepper, ... Proceedings of the National Academy of Sciences 113 (16), 4470-4475, 2016	290	2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide W Wick, P Roth, C Hartmann, P Hau, M Nakamura, F Stockhammer, ... Neuro-oncology 18 (11), 1529-1537, 2016	202	2016
Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery Z Amoozgar, J Park, Q Lin, Y Yeo Molecular pharmaceutics 9 (5), 1262-1270, 2012	178	2012
Fatty acid synthesis is required for breast cancer brain metastasis GB Ferraro, A Ali, A Luengo, DP Kodack, A Deik, KL Abbott, D Bezwada, ... Nature cancer 2 (4), 414-428, 2021	164	2021
Decitabine enhances lymphocyte migration and function and synergizes with CTLA-4 blockade in a murine ovarian cancer model L Wang, Z Amoozgar, J Huang, MH Saleh, D Xing, S Orsulic, ... Cancer immunology research 3 (9), 1030-1041, 2015	164	2015
FAP delineates heterogeneous and functionally divergent stromal cells in immune-excluded breast tumors V Cremasco, JL Astarita, AL Grauel, S Keerthivasan, K MacIsaac, ... Cancer immunology research 6 (12), 1472-1485, 2018	161	2018
The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1^−/− murine model of ovarian cancer J Huang, L Wang, Z Cong, Z Amoozgar, E Kiner, D Xing, S Orsulic, ... Biochemical and biophysical research communications 463 (4), 551-556, 2015	158	2015
Functional anti-TIGIT antibodies regulate development of autoimmunity and antitumor immunity KO Dixon, M Schorer, J Nevin, Y Etminan, Z Amoozgar, T Kondo, ... The Journal of Immunology 200 (8), 3000-3007, 2018	134	2018
Horizontal gene transfer: from evolutionary flexibility to disease progression M Emamalipour, K Seidi, S Zununi Vahed, A Jahanban-Esfahlan, ... Frontiers in cell and developmental biology 8, 229, 2020	122	2020
Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas Z Amoozgar, J Kloepper, J Ren, RE Tay, SW Kazer, E Kiner, S Krishnan, ... Nature communications 12 (1), 2582, 2021	111	2021
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy Y Xiao, J Chen, H Zhou, X Zeng, Z Ruan, Z Pu, X Jiang, A Matsui, L Zhu, ... Nature communications 13 (1), 758, 2022	107	2022
Rapidly photo-cross-linkable chitosan hydrogel for peripheral neurosurgeries TA Rickett, Z Amoozgar, CA Tuchek, J Park, Y Yeo, R Shi Biomacromolecules 12 (1), 57-65, 2011	96	2011
Targeting myeloid cells using nanoparticles to improve cancer immunotherapy Z Amoozgar, MS Goldberg Advanced drug delivery reviews 91, 38-51, 2015	77	2015
Exercise Training Improves Tumor Control by Increasing CD8⁺ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade IL Gomes-Santos, Z Amoozgar, AS Kumar, WW Ho, K Roh, NP Talele, ... Cancer immunology research 9 (7), 765-778, 2021	66	2021

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar